Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Supplementary Materials of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (7633)
All Articles published online
|
Publishing Process of This Article
|
May 18, 2017 (publication date) through Nov 23, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Hepatology
ISSN
1948-5182
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Neesgaard B, Ruhwald M, Weis N. Inducible protein-10 as a predictive marker of antiviral hepatitis C treatment: A systematic review. World J Hepatol 2017; 9(14): 677-688 [PMID: 28588752 DOI: 10.4254/wjh.v9.i14.677] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v9/i14/677.htm |
| Number | Citing Articles |
| 1 |
Jean-Baptiste Gorin, David F. G. Malone, Benedikt Strunz, Tony Carlsson, Soo Aleman, Niklas K. Björkström, Karolin Falconer, Johan K. Sandberg. Plasma FABP4 is associated with liver disease recovery during treatment-induced clearance of chronic HCV infection. Scientific Reports 2020; 10(1) doi: 10.1038/s41598-020-58768-z
|
| 2 |
Caecilia H. C. Sukowati, Riccardo Patti, Devis Pascut, Rusdina B. Ladju, Paola Tarchi, Nunzia Zanotta, Manola Comar, Claudio Tiribelli, Lory S. Crocè. Serum Stem Cell Growth Factor Beta for the Prediction of Therapy Response in Hepatocellular Carcinoma. BioMed Research International 2018; 2018: 1 doi: 10.1155/2018/6435482
|
| 3 |
Yadong Wang, Yangyang Hu, Xing Zhang, Yue Luo, Luyuan Ma, Jingjing Lu, Qianfei Liang, Chengjun Xu, Caiyan Zhao, Calvin Q. Pan. IP-10 Interferes With the Antiviral Response of Direct-Acting Antiviral Agents for Hepatitis C Virus Infection. Frontiers in Public Health 2022; 10 doi: 10.3389/fpubh.2022.911551
|
| 4 |
Chia-Chi Wang, Kuo-Chih Tseng, I-Shiang Tzeng, Jia-Horng Kao. The impact of cytokine change after hepatitis C virus clearance by direct antiviral agents on the risk of hepatocellular carcinoma. Journal of the Formosan Medical Association 2021; 120(3): 965 doi: 10.1016/j.jfma.2020.10.015
|
| 5 |
Ashraf Tabll, Reem El Shenawy, Hazem Elsharkawy, Faten Zahran Mohamed. Serum inducible protein-10 chemokine as a biomarker for clearance of HCV with and without treatment in Egyptian patients. Human Antibodies 2019; 27(4): 265 doi: 10.3233/HAB-190381
|
| 6 |
Melanie Weber, Vidya Padmanabhan Nair, Tanja Bauer, Martin F. Sprinzl, Ulrike Protzer, Michelle Vincendeau. Increased HERV-K(HML-2) Transcript Levels Correlate with Clinical Parameters of Liver Damage in Hepatitis C Patients. Cells 2021; 10(4): 774 doi: 10.3390/cells10040774
|
| 7 |
Stefania Farcomeni, Sonia Moretti, Caterina Fimiani, Lucia Fontanelli Sulekova, Fenicia Vescio, Leonardo Sernicola, Maria T. Maggiorella, Anna Lisa Remoli, Orietta Picconi, Luciana Mosca, Rozenn Esvan, Elisa Biliotti, Massimo Ciccozzi, Marco Sgarbanti, Gloria Taliani, Alessandra Borsetti. Short- and Long-Term Immunological Responses in Chronic HCV/HIV Co-Infected Compared to HCV Mono-Infected Patients after DAA Therapy. Pathogens 2021; 10(11): 1488 doi: 10.3390/pathogens10111488
|
| 8 |
Xiaodong Shi, Lijia Yu, Yinglin Zhang, Zequan Liu, Huawei Zhang, Yansong Zhang, Ping Liu, Peishuang Du. Glycyrrhetinic acid alleviates hepatic inflammation injury in viral hepatitis disease via a HMGB1-TLR4 signaling pathway. International Immunopharmacology 2020; 84: 106578 doi: 10.1016/j.intimp.2020.106578
|
| 9 |
Georg Peschel, Jonathan Grimm, Christa Buechler, Manuela Gunckel, Kirstin Pollinger, Elisabeth Aschenbrenner, Sylvia Kammerer, Ernst-Michael Jung, Michael Haimerl, Jens Werner, Martina Müller, Kilian Weigand. Liver stiffness assessed by shear-wave elastography declines in parallel with immunoregulatory proteins in patients with chronic HCV infection during DAA therapy. Clinical Hemorheology and Microcirculation 2021; 79(4): 541 doi: 10.3233/CH-211193
|
| 10 |
Robert S. Wallis, Anne O’Garra, Alan Sher, Andreas Wack. Host-directed immunotherapy of viral and bacterial infections: past, present and future. Nature Reviews Immunology 2023; 23(2): 121 doi: 10.1038/s41577-022-00734-z
|
| 11 |
Robert Wallis, Amit K. Srivastava, Andreas Wack, Charles A Knirsch. Textbook of SARS-CoV-2 and COVID-19. 2024; : 52 doi: 10.1016/B978-0-323-87539-4.00003-8
|
| 12 |
Reem El-Shenawy, Sally Farouk, Naiera Helmy, Noha Bader El Din. Hepatitis C - Recent Advances. 2023; doi: 10.5772/intechopen.1001057
|